HT
Insider selling
Helen Torley sold $153K of Halozyme Therapeutics, Inc. (HALO) stock
Helen Torley, President And CEO of Halozyme Therapeutics, Inc. (HALO), sold 1,923 shares of HALO stock worth $153K, per an SEC Form 4 filed Jul 9, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 8, 2026, 1 day before it was made public.
HALO has moved +38.7% since the trade date, from $80.37 to $111.45 (Sep 21, 2026 close).
- Traded
- Jul 8, 2026
- Disclosed
- Jul 9, 2026
- Filing delay
- 1 day
- Price since
- +38.7%
- Role
- President And CEO
- Source
- SEC Form 4
More HALO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.